1 research outputs found
Site Specific Discrete PEGylation of <sup>124</sup>I‑Labeled mCC49 Fab′ Fragments Improves Tumor MicroPET/CT Imaging in Mice
The tumor-associated glycoprotein-72
(TAG-72) antigen is highly
overexpressed in various human adenocarcinomas and anti-TAG-72 monoclonal
antibodies, and fragments are therefore useful as pharmaceutical targeting
vectors. In this study, we investigated the effects of site-specific
PEGylation with MW 2–4 kDa discrete, branched PEGylation reagents
on mCC49 Fab′ (MW 50 kDa) via in vitro TAG72 binding, and in
vivo blood clearance kinetics, biodistribution, and mouse tumor microPET/CT
imaging. mCC49Fab′ (Fab′-NEM) was conjugated at a hinge
region cysteine with maleimide-dPEG <sub>12</sub>-(dPEG<sub>24</sub>COOH)<sub>3</sub> acid (Mal-dPEG-A), maleimide-dPEG<sub>12</sub>-(dPEG<sub>12</sub>COOH)<sub>3</sub> acid (Mal-dPEG-B), or maleimide-dPEG<sub>12</sub>-(m-dPEG<sub>24</sub>)<sub>3</sub> (Mal-dPEG-C), and then
radiolabeled with iodine-124 (<sup>124</sup>I) in vitro radioligand
binding assays and in vivo studies used TAG-72 expressing LS174T human
colon carcinoma cells and xenograft mouse tumors. Conjugation of mCC49Fab′
with Mal-dPEG-A (Fab′-A) reduced the binding affinity of the
non PEGylated Fab′ by 30%; however, in vivo, Fab′-A
significantly lengthened the blood retention vs Fab′-NEM (47.5
vs 28.1%/ID at 1 h, 25.1 vs 8.4%/ID at 5 h, <i>p</i> <
0.01), showed excellent tumor to background, better microPET/CT images
due to higher tumor accumulation, and increased tumor concentration
in excised tissues at 72 h by 130% (5.09 ± 0.83 vs 3.83 ±
1.50%ID/g, <i>p</i> < 0.05). Despite the strong similarity
of the three PEGylation reagents, PEGylation with Mal-dPEG-B or -C
reduced the in vitro binding affinity of Fab′-NEM by 70%, blood
retention, microPET/CT imaging tumor signal intensity, and residual
72 h tumor concentration by 49% (3.83 ± 1.50 vs 1.97 ± 0.29%ID/g, <i>p</i> < 0.05) and 63% (3.83 ± 1.50 vs 1.42 ± 0.35%ID/g, <i>p</i> < 0.05), respectively. We conclude that remarkably
subtle changes in the structure of the PEGylation reagent can create
significantly altered biologic behavior. Further study is warranted
of conjugates of the triple branched, negatively charged Mal-dPEG-A